Invega Hafyera Prices, Coupons and Patient Assistance Programs
Invega Hafyera (paliperidone) is a member of the atypical antipsychotics drug class and is commonly used for Schizophrenia.
The cost for Invega Hafyera intramuscular suspension, extended release (1092 mg/3.5 mL) is around $13,991 for a supply of 3.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Invega Hafyera is available as a brand name drug only, a generic version is not yet available. View generic Invega Hafyera availability for more details.
Invega Hafyera prices
Intramuscular Suspension, Extended Release
Quantity | Per unit | Price |
---|---|---|
3.5 milliliters | $3,997.46 | $13,991.12 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Quantity | Per unit | Price |
---|---|---|
5 milliliters | $4,196.30 | $20,981.48 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Invega Hafyera Coupons, Copay Cards and Rebates
Invega Hafyera offers may be in the form of a printable coupon, rebate, savings or copay card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Invega Hafyera Janssen CarePath Savings Program: Eligible commercially insured patients may pay $10 per dose with a maximum savings of $8,000 per calendar year or 2 doses whichever comes first; for additional information contact the program at 877-227-3728.
- Applies to:
- Invega Hafyera
- Number of uses:
- per prescription per calendar year
Form more information phone: 877-227-3728 or Visit website
Invega Hafyera Janssen CarePath Savings Program Rebate: If the pharmacy or doctor cannot process the Savings Program Card commercially insured patients may still take advantage of the offer by submitting a rebate request; for additional information contact the program at 877-227-3728.
- Applies to:
- Invega Hafyera
- Number of uses:
- One rebate per prescription fill
Form more information phone: 877-227-3728 or Visit website
Invega Hafyera Medicare Part D Extra Help Subsidy: Patients who have Medicare Part D coverage may be eligible to apply for the Part D Extra Help Subsidy and once accepted to the program may receive reduced premiums and lower prescription costs; contact the program directly for questions or to sign-up.
- Applies to:
- Invega Hafyera
- Number of uses:
- Per prescription until program expires
Form more information phone: 800-772-1213 or Visit website
Patient Assistance & Copay Programs for Invega Hafyera
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program
Elligibility requirements:- Contact program for details.
- Varies. *See below for details
- Medication must be for outpatient use only
- The patient must also be permanently residing in the US or US territories.
- *Please call (1-800-652-6227 or visit Program website for specific FPL income requirements.
- Invega Hafyera (paliperidone palmitate) Extended-Release Injectable Suspension
More information please phone: 800-652-6227 Visit Website
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Invega Hafyera (paliperidone palmitate) Extended-Release Injectable Suspension
More information please phone: 866-316-7263 Visit Website
Provider: Janssen Support Program
Elligibility requirements:- Must have insurance
- Based on FPL
- FDA-approved diagnosis
- The patient must also be permanently residing in the US or US territories.
- This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Invega Hafyera (paliperidone palmitate) Extended-Release Injectable Suspension
More information please phone: 833-742-0791 Visit Website
More about Invega Hafyera (paliperidone)
- Check interactions
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
Other brands
Invega Sustenna, Invega, Invega Trinza